using mrd to drive maintenance therapy decisions in patients with myeloma after autosct
Published 1 year ago • 135 plays • Length 4:24Download video MP4
Download video MP3
Similar videos
-
1:27
maintenance therapy and mrd in myeloma
-
1:15
using mrd to guide treatment decisions in myeloma
-
2:55
using mrd to guide treatment decisions during sct in multiple myeloma
-
1:28
mrd negativity in myeloma patients undergoing maintenance therapy
-
1:38
using mrd to guide therapy in multiple myeloma
-
1:27
using mrd to guide treatment decisions in the clinic
-
3:43
mrd-guided treatment cessation in multiple myeloma
-
3:02
technical tips for reliable mrd assessment in patients with multiple myeloma
-
3:01
the benefit of using mrd to guide treatment decisions in multiple myeloma
-
2:17
maintenance therapy in patients with myeloma
-
3:10
the importance of mrd in multiple myeloma in guiding treatment decisions & access to therapies
-
2:31
evaluating the safety of maintenance therapy cessation in mrd negative myeloma patients
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
0:47
sustained mrd for treatment guidance in myeloma
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
3:47
using mrd to analyze the benefit of autologous sct in patients with myeloma
-
1:23
maintenance therapy for mrd negativity in mm
-
1:30
mrd: an important topic in myeloma therapy
-
1:09
using bm and pet/ct to assess mrd status in myeloma & lymphoma patients post-car-t therapy